VIP 6mg
VIP peptide, also known as vasoactive intestinal peptide, is a neuropeptide that plays a significant role in various physiological processes in the human body. Studies have indicated that VIP has demonstrated anti-inflammatory properties that can contribute to reducing inflammation throughout the body. Its effectiveness is particularly noteworthy in the context of neurodegenerative diseases, pulmonary fibrosis, inflammatory bowel disease, and cardiac fibrosis. VIP peptide exhibits significant efficacy in various fibrotic pathways, offering potential therapeutic benefits in combating the common process of fibrosis, which often leads to significant morbidity and mortality.
Beyond its antifibrotic effects, which are believed to be achieved through its anti-inflammatory actions, VIP peptide acts as a potent regulator of the immune system, exerting a general anti-inflammatory influence. Moreover, research has shown its ability to protect the central nervous system from damage and has piqued interest for its potential to preserve cognitive function in individuals with neurodegenerative diseases.
**This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This classification permits the only use of research chemicals for in vitro testing and laboratory research. This website only provides product information for educational purposes. It is illegal to introduce any form of bodily material into either people or animals. Only professionals with the appropriate training and licences should handle this product. This product may not be misbranded, used improperly, or labelled as a medication, food, or cosmetic because it is not one of those things.
Description:
VIP peptide, also known as vasoactive intestinal peptide, is a neuropeptide that plays a significant role in various physiological processes in the human body. It was initially discovered for its effects on the gastrointestinal system but has since been found to have diverse functions throughout the body.
VIP peptide is produced by certain cells in the gastrointestinal tract, as well as in the central nervous system. It acts as a neurotransmitter and hormone, exerting its effects by binding to specific receptors known as VPAC receptors. Studies have indicated that VIP has been developed for potential therapeutic use in conditions such as migraine, asthma, inflammatory bowel disease, and certain neurological disorders.
VIP Research:
VIP acts as a neurotransmitter and a hormone, exerting its effects through binding to specific receptors known as VIP receptors. These receptors are widely distributed in the central nervous system, as well as in peripheral tissues, such as smooth muscle, immune cells, and various organs.
Research on VIP peptides has revealed several potential therapeutic applications. Here are a few areas where VIP peptide research has shown promise:
- Neurological Disorders: VIP has been investigated for its potential neuroprotective and anti-inflammatory effects in neurodegenerative disorders, such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. Studies have shown that VIP can modulate immune responses and reduce neuroinflammation, which may help protect neuronal cells and improve cognitive function.
- Gastrointestinal Disorders: VIP has a significant impact on gastrointestinal motility and secretion. Research has explored its potential use in treating gastrointestinal disorders like irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and gastroparesis. VIP analogs or derivatives that selectively target VIP receptors in the gut are being studied for their ability to regulate intestinal motility and reduce inflammation.
- Respiratory Diseases: VIP has bronchodilatory properties and can modulate immune responses in the respiratory system. Research has investigated its potential in managing conditions like asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. VIP analogs or inhalation therapies are being explored to improve lung function, reduce inflammation, and enhance mucus clearance.
- Cancer Therapy: VIP receptors are overexpressed in certain types of cancer cells, making them potential targets for therapeutic interventions. Researchers have been investigating the use of VIP analogs as targeted therapies for cancers like breast cancer, lung cancer, and pancreatic cancer. VIP-based therapies aim to disrupt cancer cell proliferation, induce apoptosis, and enhance the efficacy of conventional chemotherapy.
Related products
Original price was: CAD$65.00.CAD$60.00Current price is: CAD$60.00.
Original price was: CAD$165.00.CAD$110.00Current price is: CAD$110.00.
Original price was: CAD$250.00.CAD$200.00Current price is: CAD$200.00.
Original price was: CAD$60.00.CAD$55.00Current price is: CAD$55.00.
